The experiment in vivo with tumor PDX model showed that purified RANK-N could inhibit tumor growth in vivo; however, the role and underlying mechanism of the RANKL/RANK pathway in cancer need to be further investigated. The gene discussed is TNFRSF11A; the disease is neoplasm.